BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19201886)

  • 21. An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP.
    Bell MJ; Abbott RJ; Croft NP; Hislop AD; Burrows SR
    J Virol; 2009 Mar; 83(6):2783-8. PubMed ID: 19129449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence analysis of EBV immune evasion gene BNLF2a in EBV associated tumors and healthy individuals from nasopharyngeal carcinoma endemic and non-endemic regions of China.
    Liu S; Wang X; Shu J; Zhao Z; Sun Z; Luo B
    J Med Virol; 2015 Nov; 87(11):1946-52. PubMed ID: 25959517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP.
    Luteijn RD; Hoelen H; Kruse E; van Leeuwen WF; Grootens J; Horst D; Koorengevel M; Drijfhout JW; Kremmer E; Früh K; Neefjes JJ; Killian A; Lebbink RJ; Ressing ME; Wiertz EJ
    J Immunol; 2014 Aug; 193(4):1578-89. PubMed ID: 25024387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.
    Teisserenc H; Schmitt W; Blake N; Dunbar R; Gadola S; Gross WL; Exley A; Cerundolo V
    Immunol Lett; 1997 Jun; 57(1-3):183-7. PubMed ID: 9232449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I.
    Procko E; Raghuraman G; Wiley DC; Raghavan M; Gaudet R
    Immunol Cell Biol; 2005 Oct; 83(5):475-82. PubMed ID: 16174096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
    Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
    Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins.
    Praest P; Luteijn RD; Brak-Boer IGJ; Lanfermeijer J; Hoelen H; Ijgosse L; Costa AI; Gorham RD; Lebbink RJ; Wiertz EJHJ
    Mol Immunol; 2018 Sep; 101():55-64. PubMed ID: 29879547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.
    Tan P; Kropshofer H; Mandelboim O; Bulbuc N; Hämmerling GJ; Momburg F
    J Immunol; 2002 Feb; 168(4):1950-60. PubMed ID: 11823531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.
    Abele R; Tampé R
    Physiology (Bethesda); 2004 Aug; 19():216-24. PubMed ID: 15304636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential contribution of TAP and tapasin to HLA class I antigen expression.
    Belicha-Villanueva A; McEvoy S; Cycon K; Ferrone S; Gollnick SO; Bangia N
    Immunology; 2008 May; 124(1):112-20. PubMed ID: 18194274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP).
    de la Salle H; Saulquin X; Mansour I; Klayme S; Fricker D; Zimmer J; Cazenave JP; Hanau D; Bonneville M; Houssaint E; Lefranc G; Naman R
    Clin Exp Immunol; 2002 Jun; 128(3):525-31. PubMed ID: 12067308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.